Thanks Treed ,this is an important post because I have been worried about something. New FDA rules are going to allow much quicker approvoals of new cell and gene therapy drugs. I was and am worried that big pharma will be allowed quicker approavals after we did all the hard work of 10 to 15 year trials to gain approvoal.
I am fairly confident with our patent portfolio , but I am happy we are locking up new technology.
I see these new easier guidelines to approvoals as a way to help big pharma cheat the system once again.
Cell Therapy News/Articles, page-240
-
- There are more pages in this discussion • 17,787 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 72431 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 20225 | 5 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |